M
Markus J. Barten
Researcher at Leipzig University
Publications - 160
Citations - 3453
Markus J. Barten is an academic researcher from Leipzig University. The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 29, co-authored 145 publications receiving 2864 citations. Previous affiliations of Markus J. Barten include Stanford University & Oslo University Hospital.
Papers
More filters
Journal ArticleDOI
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report
Mercè Brunet,Teun van Gelder,Anders Åsberg,Vincent Haufroid,Vincent Haufroid,Dennis A. Hesselink,Loralie J. Langman,Florian Lemaitre,Pierre Marquet,Christoph Seger,Maria Shipkova,Alexander A. Vinks,Alexander A. Vinks,Pierre Wallemacq,Eberhard Wieland,Jean-Baptiste Woillard,Markus J. Barten,Klemens Budde,Helena Colom,Maja Theresa Dieterlen,Laure Elens,Kamisha L. Johnson-Davis,Paweł K. Kunicki,Iain MacPhee,Satohiro Masuda,Binu S. Mathew,Olga Millán,Tomoyuki Mizuno,Tomoyuki Mizuno,Dirk Jan A.R. Moes,Caroline Monchaud,Ofelia Noceti,Tomasz Pawinski,Nicolas Picard,Ron H.N. van Schaik,Claudia Sommerer,Nils Tore Vethe,Brenda C. M. de Winter,Uwe Christians,Stein Bergan +39 more
TL;DR: It is concluded that considerable advances in the different fields of tacrolimus monitoring have been achieved during this last decade, and the Expert Committee concludes that Continued efforts should focus on the opportunities to implement in clinical routine the combination of new standardized PK approaches with PG, and valid biomarkers to further personalize tacolimus therapy and to improve long-term outcomes for treated patients.
Journal ArticleDOI
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
TL;DR: CsA inhibits MPAG excretion into bile and offer an explanation for the well-known increased MPA exposure in organ transplant patients caused by conversion from CsA-to TRL-based immunosuppression.
Journal ArticleDOI
Mediastinitis and Cardiac Surgery - an Updated Risk Factor Analysis in 10,373 Consecutive Adult Patients
Jan Gummert,Markus J. Barten,C. Hans,M. Kluge,Nico Doll,T Walther,B. Hentschel,D. V. Schmitt,Friedrich-Wilhelm Mohr,Anno Diegeler +9 more
TL;DR: As DSWI is related to sternotomy, a minimally invasive approach should be considered for patients at high risk for DSWI, and IMA takedown as a pedicled graft should be especially avoided in patients with diabetes.
Journal ArticleDOI
Impact of diabetes mellitus on cardiac surgery outcome.
Jan Bucerius,Jan Gummert,T Walther,Nico Doll,Volkmar Falk,J. F. Onnasch,Markus J. Barten,Friedrich-Wilhelm Mohr +7 more
TL;DR: Diabetes mellitus is a significant independent predictor for several postoperative outcome variables after cardiac surgery associated with higher postoperative morbidity and prolonged hospital stay.
Journal ArticleDOI
Therapeutic Drug Monitoring of Everolimus: A Consensus Report
Maria Shipkova,Dennis A. Hesselink,David W. Holt,Eliane M. Billaud,Teun van Gelder,Paweł K. Kunicki,Mercè Brunet,Klemens Budde,Markus J. Barten,Paolo De Simone,Eberhard Wieland,Olga López,Satohiro Masuda,Christoph Seger,Nicolas Picard,Michael Oellerich,Loralie J. Langman,Pierre Wallemacq,Raymond G. Morris,Carol Thompson,P. Marquet +20 more
TL;DR: EVR trough concentrations (C0) demonstrate a good relationship with overall exposure, providing a simple and reliable index for TDM, and a fully validated liquid chromatography tandem mass spectrometry assay is the preferred method for determination of EVR C0.